GoodRx (NASDAQ:GDRX) Rating Increased to Buy at Wall Street ZenMarket Beat·Aug 15 at 01:00 AMGDRX-3.01%
60 DEGREES PHARMACEUTICALS, INC. 2026: Revenue $207.9K, EPS ($0.9) — 10-Q SummaryTradingView·Aug 14 at 02:41 PMSXTPW0.00%SXTP+3.57%
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from BrokeragesMarket Beat·Aug 14 at 01:29 AMGDRX-3.01%
GoodRx files Form 3 for CFO, Chief Strategy & Operations Officer Justin FenglerPUBT·Aug 12 at 04:25 PMGDRX-3.01%
Hims & Hers Health Earnings: What To Look For From HIMSStock Story·Aug 8 at 10:06 PMHIMS+6.55%HIMZ+13.18%
GoodRx names Chief Strategy and Operations Officer Justin Fengler as CFO, succeeding Christopher McGinnisPUBT·Aug 5 at 04:14 PMGDRX-3.01%
GoodRx Q2 net income falls 34% to $8.5 million; revenue slips 1% to $200.4 millionPUBT·Aug 5 at 03:50 PMGDRX-3.01%
GDRX: Revenue declines as Pharma Direct and subscriptions grow, but legal and market risks remain highQuartr·Aug 5 at 03:21 PMGDRX-3.01%
Akebia Therapeutics And 2 Promising Penny Stocks To WatchSimplywall·Jul 31 at 06:13 AMSNAP+0.78%GDRX-3.01%
Market Capital Scatters: Tracking 2026 Flows from Semi Architecture to Private CreditGlobal Report·Jul 21 at 04:13 AMOPENW+22.90%SLAB-0.01%
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of "Hold" by BrokeragesMarket Beat·Jul 20 at 01:29 AMGDRX-3.01%LAZ+3.29%
